Reduction in the hepatocellular carcinoma antioncogene SLC39A14 during the malignant progression of hepatocellular carcinoma

Figure 5 Evaluation of hepatocellular carcinoma model induction efficacy. A: Appearance and hemotoxylin and eosin staining of liver lobules in the control and model groups. Abnormal mitosis of hepatocellular carcinoma cells is indicated by black arrows; magnification, 200 ×; B: Liver body ratios for the control and model mice; C: Alanine aminotransferase for the control and model mice; D: Aspartate aminotransferase for the control and model mice. H&E: Hemotoxylin and eosin; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase. ^aP < 0.001, ^bP < 0.01.